Company intelligence / Profile preview

Nannocare

Los Angeles, California, United States

Ownership: Private
Development stage: Other

Overview

Nannocare is a consumer health company specializing in innovative feminine hygiene products designed to alleviate menstrual discomfort. The company's flagship product, Nannopad, utilizes proprietary Nannogenic technology, which incorporates far-infrared (FIR) emitting minerals into the absorbent layers of the pad. This technology is intended to improve microcirculation and reduce inflammation, providing a non-invasive, drug-free alternative for managing menstrual cramps. Nannocare's product line includes various sizes of pads and liners, all marketed as organic and free from harmful chemicals.

Therapeutic areas: Women's Health
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Nannocare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nannocare.

Explore the full profile